Colds and flu

16 August 2009

GSK tests swine flu vaccine

Human trials of its swine flu vaccine have begun, says GlaxoSmithKline.

0

Human trials of its swine flu vaccine have begun, says GlaxoSmithKline.

The company plans to conduct 16 clinical trials of the vaccine in more than 9,000 people in Europe, Canada and the United States. Early results from the first trial in Germany are expected to be available in September, the Associated Press reported.

The findings will be shown to drug regulatory agencies in order to hasten their decisions about whether to approve the vaccine. Fast-track approval systems for swine flu vaccines have been created in Europe and the United States.

Earlier this month, Novartis and Sanofi-aventis began testing their swine flu vaccines, the AP reported. – (HealthDay News, August 2009)

Read more:
SA: swine flu map
World: swine flu map

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Flu expert

Dr Heidi van Deventer completed her MBChB (Bachelor of Medicine and Bachelor of Surgery) degree in 2004 at the University of Stellenbosch.
She has additional training in ACLS (Advanced Cardiac Life Support) and PALS (Paediatric Advanced Life Support) as well as biostatistics and epidemiology.

Dr Van Deventer is currently working as a researcher at the Desmond Tutu Tuberculosis Centre at the University of Stellenbosch.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules